Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Deutsche Boerse AG  >  3SBio Inc. (ADR)    YFK

No quotes available
-- EUR   0.00%
03/04 3SBIO : Bought CNY3.9bn Shares in CPGJ
03/04 3SBIO : adds stake in CP Guojian Pharma at Rmb3.9bn
02/23 3SBIO : Wins Financing for Further Equity Investment
SummaryQuotesNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M CNY Estimates in M CNY
Fiscal Period December 201320142015201620172018
Sales--1 6732 5063 1214 258
Operating income (EBITDA)--6929721 2571 465
Operating profit (EBIT)--6149161 1641 406
Pre-Tax Profit (EBT)------
Net income--5268241 0551 379
P/E ratio--39,624,118,513,5
EPS ( CNY )--0,230,320,420,57
Dividend per Share ( CNY )---0,02--
Yield---0,19%--
Reference price ( CNY )9.117.734457.734457.73445
Announcement Date--03/31/2016
11:12am
---
Finances - Leverage
Actuals in M CNY Estimates in M CNY
Fiscal Period December 201320142015201620172018
Debt---448--
Finance--894-463156
Operating income (EBITDA)--6929721 2571 465
Leverage
(Debt/EBITDA)
---0,46x--
Capital Expenditure--61,0181225143
Book Value Per Share (BVPS)---2,43  CNY2,85  CNY3,66  CNY
Cash Flow per Share--0,20  CNY0,35  CNY0,44  CNY0,59  CNY
Announcement Date01/01/1970
01:00am
01/01/1970
01:00am
03/31/2016
11:12am
---
Balance Sheet Analysis
Assessed data source :
© 2016 Thomson Reuters
Advertisement
Financial Ratios

Size 2016e 2017e
Capitalization 19 416 M CNY -
Entreprise Value (EV) 19 864 M CNY 18 953 M CNY
Valuation 2016e 2017e
P/E ratio (Price / EPS) 24,1x 18,5x
Capitalization / Revenue 7,75x 6,22x
EV / Revenue 7,93x 6,07x
EV / EBITDA 20,4x 15,1x
Yield (DPS / Price) 0,19% -
Price to book (Price / BVPS) 3,19x 2,71x
Profitability 2016e 2017e
Operating Margin (EBIT / Sales) 36,6% 37,3%
operating Leverage (Delta EBIT / Delta Sales) 0,99x 1,10x
Net Margin (Net Profit / Revenue) 32,9% 33,8%
ROA (Net Profit / Asset) 10,5% 10,4%
ROE (Net Profit / Equities) 13,7% 15,5%
Rate of Dividend 4,67% -
Balance Sheet Analysis 2016e 2017e
CAPEX / Sales   7,22% 7,20%
Cash Flow / Sales 34,7% 35,8%
Capital Intensity (Assets / Sales) 3,13x 3,24x
Financial Leverage (Net Debt / EBITDA) 0,46x -0,37x
Price Earning Ratio Help 
The blue ligne is the average P/E ratio (without estimates)
EPS & Dividend